l-carnitine tmao nature medicine 2013 koeth Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? JCI - l-Carnitine in omnivorous

JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans l carnitine tmao nature medicine 2013 koeth Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Cardiovascular risk of dietary trimethylamine L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect Dietary Fatty Acids Modulate Gut Microbiota Derived Trimethylamine N Oxide: Potential Mechanisms and Future Perspective TMAO metaorganismal pathway and chronic inflammatory diseases Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC

SKU: 90665461996 · From condeoeiras.edu.pt